A detailed history of Aigh Capital Management LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Aigh Capital Management LLC holds 1,782,490 shares of DCTH stock, worth $17.3 Million. This represents 6.51% of its overall portfolio holdings.

Number of Shares
1,782,490
Previous 2,399,792 25.72%
Holding current value
$17.3 Million
Previous $20.1 Million 19.87%
% of portfolio
6.51%
Previous 7.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.36 - $11.0 $4.54 Million - $6.79 Million
-617,302 Reduced 25.72%
1,782,490 $16.1 Million
Q2 2024

Aug 06, 2024

BUY
$4.47 - $8.37 $179,086 - $335,335
40,064 Added 1.7%
2,399,792 $20.1 Million
Q1 2024

May 14, 2024

BUY
$3.72 - $5.09 $4.38 Million - $5.99 Million
1,177,530 Added 99.61%
2,359,728 $11.3 Million
Q4 2023

Feb 12, 2024

BUY
$2.25 - $4.17 $2.66 Million - $4.93 Million
1,182,198 New
1,182,198 $4.92 Million

Others Institutions Holding DCTH

About DELCATH SYSTEMS, INC.


  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $83.3M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.